oct - 9 200 Ko3iz5 tet
51005) Summar
Submitter: Cynosure, Inc.
10 Elizabeth Drive
Chelmsford, MA 01824

Contact: George Cho
Senior Vice President of Medical Technology

Date Summary Prepared: April 9, 2003

Device Trade Name: Smart File, Smart File 6, Smarty A10

Common Name: Medical Laser System

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.48

Equivalent Device: Millennium PerioLase and Lares Research SunLase 800P

Device Description: Smart File is a Nd:YAG laser, having a Nd:YAG crystal rod as the
lasing medium. It is a laser with a wavelength of 1,064 nm.

Laser activation is by footswitch. Overall weight of the laser is 38 Kg,
and the size is 68x23x65 cm (HxWxD).
Electrical requirement is 230 VAC, 15A, 50-60 Hz, single phase.

Intended Use: The Smart File is indicated for ablation, incision, excision, coagulation
and vaporization of intraoral soft tissue.

Comparison: The Smart File laser has an equivalent indication for uses, the same
principle of operation, the same wavelength and essentially the same
pulse energy range as the predicate devices.

Nonclinical Performance Data: none

Clinical Performance Data: none

Conclusion: The Smart File laser is another safe and effective device for intraoral
soft tissue applications.

Additional Information: none

seer
f 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
s oe
ne Food and Drug Administration
ocr - 9200 ee eo
Mr. George Cho
Senior Vice President of Medical Technology
Cynosure, Inc.
10 Elizabeth Drive :
Chelmsford, Massachusetts 01824
Re: K031125
Trade/Device Name: Cynosure Smart File Laser
Smart File, SmartFile 6, Smarty A10
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology :
Regulatory Class: II
Product Code: GEX
Dated: August 28, 2003
Received: August 29, 2003
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into cither class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register. °
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. George Cho
This letter wil! allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/edrh/dsma/dsmamain.hun!

Sincerely yours.

Murer C. Peveat

Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
‘ Enclosure .

Page 1 of 1
510(k) Number (if known): _KO3| \25
Device Name: _ Cynosure Smart File Laser (Smart File, Smart File 6, Smarty Al0)
Indications For Use:
The Smart File laser device is to provide the ability to perform intraoral soft tissue, general, and oral
maxillo-facial surgery. The device is intended for ablation, incision, excision, vaporization and
coagulation of soft tissue using a contact, fiber optic delivery system. The device will be used in the
folowing areas: general dentistry, otolaryngology, dermatology and plastic surgery.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) .
Division of General, Restorative
and Neurological Devices
O311QAS
510(k) Number AY 23/2
Prescription Use. ( OR Over-The-Counter Use___
(Optional Format t-2-96)

